MCK:NYSE
McKesson Corp
961,88 US$
arrow_upward
+0,64%(+6,12) 1D
961,88 US$
0,00% (0,00)
bedtimePo uzavření burzy
Zavřeno: 13. 10., 16:00:05 GMT-4 · USD
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro MCK…
Otevřít
963,42 US$
Max.
969,48 US$
Min.
954,18 US$
Trž. kap.
112,15 mld.
Prům. obj.
848,88 tis.
Objem
0,00
Dividenda
0,39 %
Čtvrtletní dividenda
0,94 US$
Datum ex dividenda
1. 9. 2026
Ukazatel P/E
25,75
52týd. max.
999,00 US$
52týd. min.
723,68 US$
EPS
37,35 US$
Beta
0,30
Akcie v oběhu
116,59 mil.
Počet zaměstnanců
42 tis.
Otevřít
963,42 US$
Max.
969,48 US$
Min.
954,18 US$
Trž. kap.
112,15 mld.
Prům. obj.
848,88 tis.
Objem
0,00
Dividenda
0,39 %
Čtvrtletní dividenda
0,94 US$
Datum ex dividenda
1. 9. 2026
Ukazatel P/E
25,75
52týd. max.
999,00 US$
52týd. min.
723,68 US$
EPS
37,35 US$
Beta
0,30
Akcie v oběhu
116,59 mil.
Počet zaměstnanců
42 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
ad-hoc-news.de
·
před 58 minutami
McKesson stock pre-market at EUR 860.20
ad-hoc-news.de
·
před 9 hodinami
McKesson stock after-hours at EUR 860.50
Zacks
·
před 16 hodinami
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?
Yahoo Finance
·
před 1 dnem
McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal
Profil
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
Informace o McKesson Corp